Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy - Trial 2014-002713-32
Access comprehensive clinical trial information for 2014-002713-32 through Pure Global AI's free database. This phase not specified trial is sponsored by Korea UCB Co. Ltd. and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Korea UCB Co. Ltd.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Subject has a current or previous diagnosis of pseudoseizures, conversion disorders, or other non-epileptic ictal events which could be confused with seizures
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2014-002713-32
Non-Device Trial